A prospective case-control study of 150 participants found circulating cell-free DNA distinguished ovarian cancer from benign ...
The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in bladder cancer. The ...
Serum tumor markers (STMs), including alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG), are currently used in management of patients with germ cell tumors (GCTs). STMs in a substantial ...
New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...
Testing to look for circulating tumor DNA in the blood is not new. These liquid biopsies – a fancy way of saying blood tests – are already widely used for patients with advanc ...
This tutorial provides a step-by-step overview of the workflow for isolating cell-free circulating DNA from plasma or serum using the Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit.
Source: Getty Images A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy. [Editor’s note: This article was updated in June 2026 from its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results